EdU Imaging Kits (Cy5): Practical Workflow
2026-08-13
EdU Imaging Kits (Cy5) provide a click-chemistry method for labeling DNA synthesis during the S phase, with readouts suitable for fluorescence microscopy and flow cytometry. This guide explains setup, controls, and troubleshooting while noting that EdU incorporation is not, by itself, a complete measure of cell-cycle progression or proliferation rate.
Acetylcysteine: Redox and Mucus Research Guide
2026-08-12
Acetylcysteine, also called N-acetyl-L-cysteine (NAC), supplies cysteine for glutathione biology and can disrupt mucoprotein disulfide bonds. This guide links its mechanism to oxidative stress pathway modulation, respiratory disease models, hepatic protection research, and Huntington’s disease research while separating evidence-backed findings from workflow recommendations.
Nanoplastic–Cadmium Apoptosis via IP3R/Ca2+/STAT3
2026-08-12
A 2026 Toxicology study shows that combined polystyrene nanoplastic and cadmium exposure damages intestinal models through an IP3R/Ca2+/STAT3 signaling axis. Using C. elegans, Caco-2 cells, and pathway-directed inhibitors, the authors connect calcium mobilization with endoplasmic reticulum stress and apoptosis, providing a mechanistic framework for combined-pollutant toxicology.
Live-Dead Cell Staining Kit I for Translational Oncology
2026-08-11
A mechanistic and strategic guide to using Calcein AM/PI fluorescence to validate treatment response, distinguish membrane failure from broader cell-death biology, and strengthen translational oncology decisions.
Obacunone, Akt/p53 Signaling, and Ferroptosis
2026-08-10
A 2025 study shows that obacunone suppresses ovarian cancer growth by promoting ferroptosis and altering the Akt/p53 axis. Using cell and xenograft models, the investigators connected reduced Akt phosphorylation, enhanced p53 expression, glutathione depletion, GPX4 loss, and ACSL4 induction with ferroptotic tumor-cell injury.
T0070907: Practical PPARγ Antagonist Workflows
2026-08-09
T0070907 enables controlled interrogation of PPARγ transcription, adipogenesis, macrophage inflammation, and cancer-associated cell-cycle phenotypes. This workflow-focused guide shows how to separate receptor-dependent activity from compound-related artifacts and translate RXRα/PPARγ findings into reproducible assays.
WP1066 Workflow for JAK2/STAT3 Research
2026-08-08
WP1066 is a cell-permeable JAK2/STAT3 inhibitor for connecting pathway phosphorylation events with cancer-cell phenotypes and immune-regenerative mechanisms. This workflow covers dose selection, phospho-protein validation, renal carcinoma and AML applications, and a cautious extension into macrophage-centered bone-repair research.
EdU Imaging Kits (HF594) for PNI Research
2026-08-07
EdU Imaging Kits (HF594) turn S-phase DNA synthesis into a quantitative fluorescence readout for pancreatic cancer, Schwann-cell, and drug-response experiments. Their antibody-free click-chemistry workflow supports microscopy and flow cytometry while avoiding the DNA-denaturation step required by conventional BrdU assays.
Protease Inhibitor Cocktail: Enhancing Protein Stability in
2026-08-07
The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) by APExBIO is engineered for uncompromised protein integrity during cell and tissue extraction, especially in high-demand OXPHOS and signaling workflows. Its broad-spectrum, EDTA-free formulation offers seamless compatibility with kinase and metalloprotein assays where chelator interference must be avoided.
ALDOB K87 Lactylation Orchestrates Mitochondrial Fission in
2026-08-06
Yi et al. identify ALDOB K87 lactylation as a central regulator of mitochondrial fission and metabolic reprogramming in pulmonary hypertension by connecting lactate-driven post-translational modification to enhanced smooth muscle cell proliferation. This mechanistic insight offers new avenues for targeting vascular remodeling in PH, with clear implications for cellular assay design and translational research.
Triiodothyronine (T3): Mechanistic Insights and Assay Precis
2026-08-06
Explore the mechanistic role of Triiodothyronine (T3) in thyroid hormone receptor activation and advanced signaling assays. This article delivers a unique perspective on T3’s use in high-fidelity cellular models, bridging molecular detail and practical assay choices.
BV6 IAP Antagonist: Precision Tools for Translational Apopto
2026-08-05
This thought-leadership article explores the strategic integration of BV6, a selective IAP antagonist, into translational research pipelines. Bridging mechanistic insights with actionable guidance, we highlight how BV6 advances the study of apoptosis and radiosensitization in cancer and endometriosis models, referencing both recent mechanistic studies and scenario-driven workflow solutions. The discussion expands beyond routine product summaries to address reproducibility, cross-indication applicability, and future directions in apoptosis research.
Machine Learning Accelerates LNP Design for mRNA Vaccines
2026-08-05
This study introduces a machine learning-based prediction model for optimizing ionizable lipid nanoparticle (LNP) formulations in mRNA vaccine development. By integrating computational screening with molecular modeling and experimental validation, the work streamlines identification of effective lipid structures such as SM-102, offering a data-driven route to more efficient mRNA delivery systems.
Deferasirox (Exjade): Oral Chelation Advances for Iron Overl
2026-08-04
The reference study establishes Deferasirox (Exjade) as the first oral tridentate chelator approved for transfusional iron overload, providing a clinically validated alternative to parenteral deferoxamine. Its efficacy, tolerability, and oral administration address major barriers in chronic anemia management, with significant implications for patient adherence and long-term outcomes.
Foretinib (GSK1363089): Multikinase Inhibitor for Tumor Rese
2026-08-04
Foretinib (GSK1363089) is a potent ATP-competitive multikinase inhibitor that targets VEGFRs and MET/HGFR, showing sub-nanomolar inhibition of key kinases involved in cancer progression. It induces G2/M arrest, inhibits cell motility, and reduces tumor growth and metastasis in preclinical models, making it a valuable tool for translational cancer research.
508 records 12/34 page Previous Next First page 上5页 1112131415 下5页 Last page